{"id":"NCT02573883","sponsor":"Medstar Health Research Institute","briefTitle":"Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus","officialTitle":"A Randomized Trial of Clobetasol Propionate Versus Fractionated CO2 Laser for the Treatment of Lichen Sclerosus (CuRLS)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-10","primaryCompletion":"2019-09","completion":"2019-09","firstPosted":"2015-10-12","resultsPosted":"2021-10-12","lastUpdate":"2021-10-12"},"enrollment":52,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Vulvar Lichen Sclerosus"],"interventions":[{"type":"DEVICE","name":"Fractionated Carbon Dioxide Laser","otherNames":["SmartXide -V2-LR system","Mona Lisa Laser"]},{"type":"DRUG","name":"Clobetasol Propionate 0.05% ointment","otherNames":["Temovate Propionate 0.05% ointment"]}],"arms":[{"label":"Prior Clobetasol Exposure","type":"EXPERIMENTAL"},{"label":"No Prior Clobetasol Exposure","type":"ACTIVE_COMPARATOR"}],"summary":"This study is being done to compare the effects, good and bad, of fractionated CO2 laser treatment and clobetasol propionate .05% ointment on vulvar lichen sclerosus.","primaryOutcome":{"measure":"Change in SkinDEX-29 Score","timeFrame":"Change from baseline score to score at six months","effectByArm":[{"arm":"Fractionated Carbon Dioxide Laser","deltaMin":-16.83,"sd":18.09},{"arm":"Clobetasol Propionate","deltaMin":-5.92,"sd":5.81}],"pValues":[{"comp":"OG000 vs OG001","p":"0.007"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":12},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["22161424","24605832","25539748","33957642"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":27},"commonTop":["minor burning and blistering at treatment site","Activation Genital Herpes"]}}